Will vaccine expectations fade? Will the risk-on continue?! [Market Wizard Nao Okumura's Market Commentary]
Vaccine development is led by Pfizer and BioNTech. Other companies have followed suit.
With vaccine expectations, the market moved into a risk-on stance. However, that too slowed down quickly. What on earth is going on? Market wizard Okumura explains.
The first half covers the usual infection data and vaccines.
(Recording date: 2020.11.19)
Trio Asset Management Co., Ltd.
× ![]()